Cargando…

Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007616/
http://dx.doi.org/10.1182/blood-2014-03-564831
_version_ 1782314357235908608
collection PubMed
description
format Online
Article
Text
id pubmed-4007616
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-40076162014-05-06 Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300. Blood Errata American Society of Hematology 2014-05-01 /pmc/articles/PMC4007616/ http://dx.doi.org/10.1182/blood-2014-03-564831 Text en © 2014 by The American Society of Hematology
spellingShingle Errata
Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.
title Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.
title_full Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.
title_fullStr Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.
title_full_unstemmed Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.
title_short Diffner E, Beck D, Gudgin E, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121(12):2289-2300.
title_sort diffner e, beck d, gudgin e, et al. activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. blood. 2013;121(12):2289-2300.
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007616/
http://dx.doi.org/10.1182/blood-2014-03-564831